Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt.

Nevin Hammam Samar Tharwat Rawhya R El Shereef Ahmed M Elsaman Noha M Khalil Hanan M Fathi Mohamed N Salem Hanan El Saadany Nermeen Samy Amany S El-Bahnasawy Yousra Hisham Abdel-Fattah Marwa Abdullah Amer Emad Elshebini Amira T El-Shanawany Dina H El-Hammady Rasha Abdel Noor Marwa ElKhalifa Faten Ismail Rasha M Fawzy Amany R El-Najjar Zahraa I Selim Nouran M Abaza Ahmed R Radwan Mervat I Abd Elazeem Wael Abdel Mohsen Abdel Hafeez Moshrif Alzahra Abdelbadea Loay I Aglan Soha Senara Maha Emad Ibrahim Iman A S Khalifa Rasha El Owaidy Noha El Fakharany Reem Hamdy A Mohammed Tamer A Gheitanull null

Published in: Rheumatology international (2021)

The results of the study and specifically the low rate of acceptability are alarming to Egyptian health authorities and should stir further interventions to reduce the levels of vaccine hesitancy. As rheumatic disease patients in Egypt were not systematically provided with the vaccine till present, making the vaccine available could as well enhance vaccine acceptance. Further studies to investigate any possible side effects, on a large scale of RD patients are warranted.

Keyphrases